Note 9 - Segment Information

9 Months Ended

Mar. 31, 2015

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 9. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended March 31, 2015 and 2014 were $2,174 and $2,113, respectively and for the nine months ended March 31, 2015 and 2014 were $6,570 and $8,369, respectively.

Financial information relating to the three months ended March 31, 2015 and 2014 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2015	$	6,893	$	1,805	$	8,698	$	681		$	70	$	39
	2014		4,713		2,058		6,771		643			57		86
Branded Proprietary Products	2015		82		300		382		(5	)		-		-
	2014		147		45		192		(64	)		1		-
Other Nutraceutical Businesses	2015		522		69		591		223			1		-
	2014		549		10		559		148			2		-
Total Company	2015		7,497		2,174		9,671		899			71		39
	2014		5,409		2,113		7,522		727			60		86

Financial information relating to the nine months ended March 31, 2015 and 2014 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2015	$	20,272	$	5,876	$	26,148	$	2,965		$	200	$	412
	2014		15,115		7,739		22,854		3,217			185		166
Branded Proprietary Products	2015		280		586		866		(74	)		1		1
	2014		409		527		936		100			2		-
Other Nutraceutical Businesses	2015		1,422		108		1,530		565			1		-
	2014		1,608		103		1,711		476			8		2
Total Company	2015		21,974		6,570		28,544		3,456			202		413
	2014		17,132		8,369		25,501		3,793			195		168

	Total Assets as of
	March 31,		June 30,
	2015		2014
Contract Manufacturing	$	9,021	$	7,752
Branded Proprietary Products		1,441		1,781
Other Nutraceutical Businesses		1,958		2,050
Total Company	$	12,420	$	11,583